Ke Yong-Sheng, Wang De-Guo, Wang He-Gui, Yang Shang-Yin
Department of Cardiology, Yijishan Hospital, Wannan Medical College, Wuhu, 241001 China.
Cardiovasc Drugs Ther. 2004 Jul;18(4):289-93. doi: 10.1023/B:CARD.0000041248.20065.47.
To elucidate whether endoxin is one of important factors involved in myocardial ischemia reperfusion (MIR) injury, the change of myocardial endoxin level was determined in rats with MIR injury model and the effects of anti-digoxin antiserum (ADA), an endoxin specific antagonist, on MIR injury were studied.
MIR injury model was obtained by ligating left anterior descending coronary artery 30 min followed by 45 min reperfusion. Sprague-Dawley rats were randomly divided into six groups of 10 rats, each. Sham group, MIR group, normal saline group, ADA 9, 18 and 36 mg.kg(-1). ECG was continuously recorded. After reperfusion left ventricular myocardium samples of ischemic area were processed immediately. Myocardial endoxin level, Na(+)-K(+)-ATPase, Ca(2+)-ATPase, Mg(2+)-ATPase activities, and intramitochondrial Ca(2+) content were measured.
Myocardial endoxin level was significantly increased; Na(+)-K(+)-ATPase, Ca(2+)-ATPase, and Mg(2+)-ATPase activities were remarkably decreased; intramitochondrial Ca(2+) content was remarkably raised; ST segments of ECG were significantly elevated and occurrence and scores of ventricular arrhythmias were significantly increased in early stage of reperfusion in rats with MIR. In all groups with ADA, myocardial endoxin level was remarkably decreased; Na(+)-K(+)-ATPase, Ca(2+)-ATPase and Mg(2+)-ATPase activities were drastically increased; intramitochondrial Ca(2+) content was declined; ST segments and ventricular arrhythmias were improved.
Myocardial endoxin level was increased in MIR, which implies that the elevated endoxin may be one of major factors inducing MIR injury. This postulate is supported by the observation that ADA has protective and therapeutic effects against MIR injury probably by antagonizing the action of endoxin. The underlying mechanism may be ascribed to restoration of energy metabolism, and attenuation of intracellular Ca(2+) overload.
为阐明内毒素是否为参与心肌缺血再灌注(MIR)损伤的重要因素之一,本研究测定了MIR损伤模型大鼠心肌内毒素水平,并研究了内毒素特异性拮抗剂抗地高辛抗血清(ADA)对MIR损伤的影响。
通过结扎左冠状动脉前降支30分钟,随后再灌注45分钟建立MIR损伤模型。将Sprague-Dawley大鼠随机分为六组,每组10只。假手术组、MIR组、生理盐水组、ADA 9、18和36mg·kg⁻¹组。连续记录心电图。再灌注后立即处理缺血区左心室心肌样本。测定心肌内毒素水平、Na⁺-K⁺-ATP酶、Ca²⁺-ATP酶、Mg²⁺-ATP酶活性以及线粒体内Ca²⁺含量。
MIR大鼠再灌注早期心肌内毒素水平显著升高;Na⁺-K⁺-ATP酶、Ca²⁺-ATP酶和Mg²⁺-ATP酶活性显著降低;线粒体内Ca²⁺含量显著升高;心电图ST段显著抬高,室性心律失常的发生率和评分显著增加。在所有给予ADA的组中,心肌内毒素水平显著降低;Na⁺-K⁺-ATP酶、Ca²⁺-ATP酶和Mg²⁺-ATP酶活性大幅增加;线粒体内Ca²⁺含量下降;ST段和室性心律失常得到改善。
MIR时心肌内毒素水平升高,这表明内毒素升高可能是诱导MIR损伤的主要因素之一。ADA可能通过拮抗内毒素的作用对MIR损伤具有保护和治疗作用,这一观察结果支持了这一假设。其潜在机制可能归因于能量代谢的恢复以及细胞内Ca²⁺超载的减轻。